Document:

Filed by Automated Filing Services Inc. (604) 609-0244 - Imvision Therapeutics Inc. - Exhibit 10.11

EXHIBIT 10.11

THE SECURITIES OFFERED HEREBY HAVE NOT BEEN REGISTERED UNDER
THE SECURITIES ACT OF 1933 (THE "ACT"), AND ARE BEING OFFERED AND SOLD IN
RELIANCE UPON EXEMPTIONS FROM THE REGISTRATION REQUIREMENTS OF THE ACT. SUCH
SECURITIES MAY NOT BE REOFFERED FOR SALE OR RESOLD OR OTHERWISE TRANSFERRED
UNLESS THEY ARE REGISTERED UNDER THE APPLICABLE PROVISIONS OF THE ACT OR ARE
EXEMPT FROM SUCH REGISTRATION. THESE SECURITIES HAVE NOT BEEN APPROVED OR
DISAPPROVED BY THE SECURITIES AND EXCHANGE COMMISSION (THE "COMMISSION") OR BY
ANY STATE SECURITIES ADMINISTRATION OR REGULATORY AUTHORITY.

SUBSCRIPTION AGREEMENT

IMVISION THERAPEUTICS INC.

SUBSCRIPTION AGREEMENT (the “Subscription Agreement”)
made effective as of the 30th day of June, 2006 between ImVisioN
Therapeutics Inc., a Nevada corporation (the "Company") and the
undersigned subscriber (the "Subscriber").

WHEREAS:

A.         
             The
Company has approved the offering of up to 7,925,000 shares of the Company’s
common stock, par value US$0.001 per share at a price of US$0.001 per share to
certain founders of the Company (the “Offering”).

B.                      
The Subscriber is a founder of the Company and desires to acquire the number of
shares of the Company’s common stock as set forth on the execution page of this
Agreement (the "Shares") on the terms and subject to the conditions of this
Subscription Agreement.

C.                      
The Company desires to accept the Subscriber’s subscription for the Shares.

NOW, THEREFORE, for and in consideration of the premises
and the mutual covenants hereinafter set forth, the parties hereto do hereby
agree as follows:

1.                      
Subscription for Shares

1.1                    
Subject to the terms and conditions hereinafter set forth, the Subscriber hereby
subscribes for and agrees to purchase the Shares from the Company at a price
equal to US$0.001 per Share and the Company agrees to sell the Shares to the
Subscriber.

1.2                    
The purchase price is payable by the Subscriber to the Company contemporaneously
with the execution and delivery of this Subscription Agreement.

1.3                    
The certificates representing the Shares sold pursuant to this Offering will be
“restricted shares”, as contemplated under United States Securities Act of 1933
(the “Securities Act”), and will be endorsed with the following legend:

  
    “THE SECURITIES REPRESENTED BY THIS CERTIFICATE
      HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 (THE "ACT"), AND
      HAVE BEEN ISSUED IN RELIANCE UPON EXEMPTIONS 

  

- 1 -

  
    FROM THE REGISTRATION REQUIREMENTS OF THE ACT. SUCH
      SECURITIES MAY NOT BE REOFFERED FOR SALE OR RESOLD OR OTHERWISE TRANSFERRED
      UNLESS THEY ARE REGISTERED UNDER THE APPLICABLE PROVISIONS OF THE ACT OR
      ARE EXEMPT FROM SUCH REGISTRATION.”

  

1.4                    
The Subscriber hereby authorizes and directs the Company to deliver the
securities to be issued to such Subscriber pursuant to this Subscription
Agreement to the Subscriber’s address indicated herein.

2.                      
Representations and Warranties of Subscriber

2.1                    
The Subscriber hereby agrees with and represents and warrants to the Company as
follows:

	 	(a) 	
      the Subscriber recognizes that the purchase of Shares
      involves a high degree of risk in that the Company has only recently
      commenced its proposed business and will require substantial funds in
      addition to the proceeds of this subscription;

	 	 	 
	 	(b) 	
      an investment in the Company is highly speculative and
      only investors who can afford the loss of their entire investment should
      consider investing in the Company and the Shares;

	 	 	 
	 	(c) 	
      the Subscriber has such knowledge and experience in
      finance, securities, investments, including investment in non-listed and
      non registered securities, and other business matters so as to be able to
      evaluate the merits and risks of an investment in the Company’s common
      stock and to otherwise protect its interests in connection with this
      transaction;

	 	 	 
	 	(d) 	
      the Subscriber acknowledges that no market for the Shares
      presently exists and none may develop in the future and accordingly the
      Subscriber may not be able to liquidate its investment;

	 	 	 
	 	(e) 	
      the Subscriber hereby acknowledges that this offering of
      Shares by the Company has not been reviewed by the United States
      Securities and Exchange Commission ("SEC") and that the Shares are being
      issued by the Company pursuant to an exemption from registration provided
      by Section 4(2) to the United States Securities Act;

	 	 	 
	 	(f) 	
      the Subscriber has not purchased the Shares as a result
      of any form of general solicitation or general advertising, including
      advertisements, articles, notices or other communications published in any
      newspaper, magazine or similar media or broadcast over radio, television
      or other form of telecommunications, or any seminar or meeting whose
      attendees have been invited by general solicitation or general
      advertising;

	 	 	 
	 	(g) 	
      the Subscriber understands that the Shares are
      “restricted securities” under applicable federal securities laws and that
      the Securities Act and the rules of the SEC provide in substance that the
      Subscriber may dispose of the Shares only pursuant to an effective
      registration statement under the Securities Act or an exemption from the
      registration requirements of the Securities Act;

	 	 	 
	 	(h) 	
      If the Subscriber decides to offer, sell or otherwise
      transfer any of the Shares, it will not offer, sell or otherwise transfer
      any of such Shares directly or indirectly, unless:

	 	 	 
	 		
      (i)      the sale is to the
      Company;

- 2 -

	 	(ii) 	
      the sale is made outside the United States in a
      transaction meeting the requirements of Rule 904 of Regulation S under the
      Securities Act and in compliance with applicable local laws and
      regulations;

	 	 	 
	 	(iii) 	
      the sale is made pursuant to the exemption from the
      registration requirements under the Securities Act provided by Rule 144
      thereunder and in accordance with any applicable state securities or “blue
      sky” laws; or

	 	 	 
	 	(iv) 	
      the Shares are sold in a transaction that does not
      require registration under the Securities Act or any applicable state laws
      and regulations governing the offer and sale of
  securities,

	 		
      and, in the cases of (iii) and (iv), it has prior to such
      sale furnished to the Company an opinion of counsel reasonably
      satisfactory to the Company.

	 	 	 
	 	(i) 	
      the Subscriber is acquiring the Shares subscribed to
      hereunder as an investment for Subscriber's own account, not as a nominee
      or agent, and not with a view toward the resale or distribution of any
      part thereof, and Subscriber has no present intention of selling, granting
      any participation in, or otherwise distributing the same;

	 	 	 
	 	(j) 	
      the Subscriber does not have any contract, undertaking,
      agreement or arrangement with any person to sell, transfer or grant
      participation to such person, or to any third person, with respect to any
      of the Shares sold hereby; and

	 	 	 
	 	(k) 	
      the Subscriber has full power and authority to enter into
      this Agreement which constitutes a valid and legally binding obligation,
      enforceable in accordance with its terms.

3.                      
Company Representations

3.1                    
The Company represents and warrants to the Subscriber and acknowledges that the
Subscriber is relying upon such representations and warranties in connection
with the execution, delivery and performance of this Agreement:

	 	(a) 	
      the Company is a corporation duly incorporated and in
      good standing under the laws of the State of Nevada, and has the requisite
      corporate power and authority to conduct its business as it is currently
      being conducted;

	 	 	 
	 	(b) 	
      the issuance of the Shares has been duly authorized and,
      when issued upon payment thereof in accordance with this Agreement, will
      have been validly issued, fully paid and non-assessable;

	 	 	 
	 	(c) 	
      the Company has the requisite corporate power and
      authority to enter into and to consummate the transactions contemplated by
      the Subscription Agreement; and

	 	 	 
	 	(d) 	
      the execution and delivery by the Company of the
      Subscription Agreement have been duly authorized by all necessary action
      on the part of the Company.

- 3 -

4.                      
Miscellaneous

4.1                    
Notwithstanding the place where this Subscription Agreement may be executed by
any of the parties hereto, the parties expressly agree that all the terms and
provisions hereof shall be construed in accordance with and governed by the laws
of the State of Nevada.

4.2                    
The parties agree to execute and deliver all such further documents, agreements
and instruments and take such other and further action as may be necessary or
appropriate to carry out the purposes and intent of this Subscription
Agreement.

IN WITNESS WHEREOF, this Subscription Agreement is
executed as of the day and year first written above.

	Number of Shares Subscribed For: 	Shares 
	 	 
	Purchase Price: 	US$0.001 per Share 
	 	 
	Aggregate Purchase Price: 	US$ 
	 	 
	Signature of Subscriber or Authorized 	  
	Signatory of Subscriber: 	  
	 	 
	Name of Authorized Signatory of 	  
	Subscriber (if Subscriber is not an 	  
	individual): 	  
	 	 
	Title of Authorized Signatory of 	  
	Subscriber(if Subscriber is not an 	  
	individual): 	  
	 	 
	Name of Subscriber: 	  
	 	 
	Address of Subscriber: 	  
	 	 
	  	  
	 	 
	ACCEPTED BY: 	  
	 	 
	IMVISION THERAPEUTICS INC. 	  
	 	 
	Signature of Authorized Signatory: 	  
	 	 
	Name of Authorized Signatory: 	  
	 	 
	Position of Authorized Signatory: 	  

- 4 -

	 	 
	 	 
	Date of Acceptance: 	June ___, 2006 

 

- 5 -Filed by Automated Filing Services Inc. (604) 609-0244 - Imvision Therapeutic Inc. - Exhibit 10.12

EXHIBIT 10.12

RESTRICTED STOCK PURCHASE AGREEMENT

THIS AGREEMENT is made effective as of June 30, 2006,

AMONG:

IMVISION THERAPEUTICS INC., a
Nevada corporation with an 
address at Feodor-Lynen Str. 5, 30625, Hannover,
Germany

(the “Corporation”)

AND:

The Undersigned Shareholder of the
Corporation 

(the “Shareholder”) 

WHEREAS:

(A)             
         The Shareholder has purchased
that number of shares of the Corporation’s common stock set forth on the
execution page to this Agreement at a price of $0.001 per share (the
“Shares”).

(B)         
             The
Shareholder has agreed that the Corporation has the right to repurchase the
Shares in the event that the Corporation’s common stock does not become eligible
for trading on the NASD OTC Bulletin Board by March 31, 2007.

THIS AGREEMENT WITNESSES THAT the Parties, intending to
be legally bound, covenant and agree as follows:

Escrow

1.1                    
The Shares will be held by the Corporation in escrow in accordance with the
terms of this Agreement during the period (the “Escrow Period”) from the date of
this Agreement until date which is the earlier of:

(a)          
the date that the Corporation’s common stock becomes eligible for trading on the
NASD OTC Bulletin Board (the “Vesting Event”); and 

(b)          
March 31, 2007 (the “Termination Date”).

Restrictions on Ownership Pending Vesting

1.2                    
During the Escrow Period, the Shareholder agrees:

(a)          
the Shareholder will not sell, transfer, pledge, assign or otherwise dispose of
the Shares or an interest in the Shares; and

(b)          
the certificates representing the Shares will be held by the Corporation in
trust pending release in accordance with this Agreement.

- 2 -

Vesting

1.3                    
The Shareholder’s right to a release of the Shares will vest on the Vesting
Event, provided that the Vesting Event takes place on or before the Termination
Date. Upon achievement of the Vesting Event, the certificates representing the
Shares will be released by the Corporation to the Shareholder and this Agreement
will forthwith terminate and be of no further force or effect.

Corporation Right of Repurchase

1.4                    
In the event that the Vesting Date has not taken place on or before the
Termination Date, the Corporation will be entitled re-purchase the shares at a
price of $0.001 per Share, which re-purchase will be completed as follows:

(a)          
the Corporation will deliver payment of the purchase price to the Shareholder;
and

(b)          
the certificates representing the Shares will be released to the
Corporation.

Effect of Repurchase

1.5                    
Upon repurchase of the Shares in accordance with this Agreement, the Shareholder
will have no further right, title or interest in the Shares and this Agreement
will terminate and be of no further force or effect.

Governing Law and Attornment

1.6                    
This Agreement will be exclusively governed by, and interpreted and construed in
accordance with, the laws prevailing in the State of Nevada.

Time of Essence

1.7                    
Time is of the essence in the performance of each obligation under this
Agreement.

Entire Agreement

1.8                    
This Agreement constitutes the entire agreement between the Parties and
supersedes all prior agreements and understandings, oral or written, by and
between any of the Parties with respect to the subject matter hereof.

Further Assurances

1.9                    
The Parties will with reasonable diligence, do all such things and provide all
such reasonable assurances as may be required to consummate the transactions
contemplated by this Agreement, and each Party will provide such further
documents or instruments required by the other Party as may be reasonably
necessary or desirable to give effect to the purpose of this Agreement.

- 3 -

Counterparts

1.10                    This
Agreement may be executed in any number of counterparts, in original form or by
facsimile, each of which will together, for all purposes, constitute one and the
same instrument, binding on the parties, and each of which will together be
deemed to be an original, notwithstanding that each party is not a signatory to
the same counterpart.

IN WITNESS WHEREOF the Parties have duly executed this
Agreement effective as of the day and year first above written.

IMVISION THERAPEUTICS INC.

	Per: 		 
	 	Authorized Signatory 	 

	Number of Shares Held: 	Shares 
	  	  
	Signature of Shareholder or Authorized 	  
	Signatory of Shareholder: 	 
    
	  	  
	Name of Authorized Signatory of 	  
	Subscriber (if Subscriber is not an 	  
	individual): 	 
    
	  	  
	Title of Authorized Signatory of 	  
	Shareholder (if Shareholder is not an 	  
	individual): 	 
    
	  	  
	  	  
	Name of Shareholder: 	 
    
	  	  
	Address of Shareholder:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00109-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00109-of-00352.parquet"}]]